Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionTwin Tree Management, LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Twin Tree Management, LP ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 14, 2026 - Twin Tree Management, LP filed a 13F-HR form disclosing ownership of 0 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 3,641 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Twin Tree Management, LP has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 3,200 of underlying shares valued at $1,058,784 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -3,641 -100.00 0 -100.00
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,641 -12,364 -77.25 1,448 -80.17 0.0126
2025-11-13 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 16,005 16,005 7,298 0.0304
2025-07-28 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -7,074 -100.00 0 -100.00
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,074 7,074 1,910 0.0036
2024-11-13 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -43,749 -100.00 0 -100.00
2024-08-13 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 43,749 28,239 182.07 10,631 358.83 0.0240
2024-05-09 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,510 15,510 2,318 0.0051
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -6,289 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,289 6,289 1,114 0.0025
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -72,861 -100.00 0 -100.00
2022-11-10 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 72,861 63,421 671.83 14,584 959.11 0.0279
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,440 -22,344 -70.30 1,377 -73.47 0.0022
2022-05-11 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 31,784 31,784 5,190 0.0083
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -16,500 -100.00 0 -100.00
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 16,500 16,500 2,797 0.0075
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -134 -100.00 0 -100.00
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 134 117 688.24 20 566.67 0.0001
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 17 17 -87.31 3 -85.00 0.0000
2019-05-10 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -5,919 -100.00 0 -100.00
2019-02-13 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,919 -18,788 -76.04 432 -80.02 0.0027
2018-11-09 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 24,707 16,180 189.75 2,162 157.38 0.0147
2018-08-07 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,527 8,527 840 0.0052
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 3,200 -63.64 1,059 -69.76 n/a n/a n/a
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 8,800 3,499 n/a n/a n/a
2025-11-13 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-07-28 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 36,800 -24.28 12,000 -8.55 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 48,600 -46.00 13,123 -38.04 n/a n/a n/a
2025-02-10 2024-12-31 13F ALNYLAM PHARMACEUTICALS ORDINARY SHARES Call 90,000 -36.75 21,178 -45.89 n/a n/a n/a
2024-11-13 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 142,300 39,137 n/a n/a n/a
2024-08-13 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-09 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,900 -80.79 433 -85.02 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 15,100 2,890 n/a n/a n/a
2023-05-10 2023-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 83,600 0.00 19,868 18.73 n/a n/a n/a
2022-11-10 2022-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 83,600 16,733 n/a n/a n/a
2022-02-09 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 4,200 -90.14 793 -89.02 n/a n/a n/a
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 42,600 7,222 n/a n/a n/a
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 -32.13 2,222 -7.65 n/a n/a n/a
2020-05-13 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 22,100 211.27 2,406 194.13 n/a n/a n/a
2020-02-14 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 7,100 -67.87 818 -66.00 n/a n/a n/a
2019-08-12 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-10 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,500 2,828.57 1,916 3,656.86 n/a n/a n/a
2019-02-13 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 700 -56.25 51 -63.57 n/a n/a n/a
2018-11-09 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 1,600 14.29 140 1.45 n/a n/a n/a
2018-08-07 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 1,400 -97.57 138 -97.99 n/a n/a n/a
2018-05-09 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 57,700 -57.60 6,872 -60.26 n/a n/a n/a
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 136,100 84.42 17,292 99.42 n/a n/a n/a
2017-11-13 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 73,800 8,671 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 22,000 147.19 8,748 115.57 n/a n/a n/a
2025-11-13 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 8,900 -59.36 4,058 -43.17 n/a n/a n/a
2025-07-28 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 21,900 -56.02 7,141 -46.89 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 49,800 666.15 13,447 779.40 n/a n/a n/a
2025-02-10 2024-12-31 13F ALNYLAM PHARMACEUTICALS ORDINARY SHARES Put 6,500 -87.76 1,530 -89.53 n/a n/a n/a
2024-11-13 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 53,100 365.79 14,604 427.22 n/a n/a n/a
2024-08-13 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,400 -50.86 2,770 -20.10 n/a n/a n/a
2024-05-09 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 23,200 3,467 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 7,900 1,399 n/a n/a n/a
2023-05-10 2023-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 323,600 -19.32 76,904 -4.21 n/a n/a n/a
2022-11-10 2022-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 401,100 11,041.67 80,284 15,192.19 n/a n/a n/a
2022-08-11 2022-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 3,600 -96.45 525 -96.83 n/a n/a n/a
2022-05-11 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 101,500 16,574 n/a n/a n/a
2022-02-09 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 10,000 566.67 1,888 643.31 n/a n/a n/a
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 1,500 254 n/a n/a n/a
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 2,200 320 n/a n/a n/a
2019-08-12 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-10 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 1,400 -81.58 131 -76.35 n/a n/a n/a
2019-02-13 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 7,600 -86.23 554 -88.53 n/a n/a n/a
2018-11-09 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 55,200 481.05 4,831 416.13 n/a n/a n/a
2018-08-07 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 9,500 0.00 936 -17.24 n/a n/a n/a
2018-05-09 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 9,500 163.89 1,131 147.48 n/a n/a n/a
2018-02-09 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 3,600 0.00 457 8.04 n/a n/a n/a
2017-11-13 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 3,600 423 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.